Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
ASSETS    
Available-for-sale securities, at fair value (amortized cost $7,139,506 and $7,005,013, respectively; allowance for credit losses $11,573 and $14,238, respectively) $ 6,970,718 $ 7,161,703
Mortgage servicing rights, at fair value 3,089,963 2,191,578
Cash and cash equivalents 620,214 1,153,856
Restricted cash 855,930 934,814
Accrued interest receivable 25,160 26,266
Due from counterparties 302,302 168,449
Derivative assets, at fair value 58,496 80,134
Reverse repurchase agreements 138,625 134,682
Other assets 212,400 262,823
Total Assets 12,273,808 12,114,305
Liabilities    
Repurchase agreements 7,872,656 7,656,445
Revolving credit facilities 570,761 420,761
Term notes payable 397,074 396,776
Convertible senior notes 281,403 424,827
Derivative liabilities, at fair value 127,529 53,658
Due to counterparties 187,891 196,627
Dividends payable 72,558 72,412
Accrued interest payable 9,991 18,382
Commitments and contingencies (see Note 15) 0 0
Other liabilities 124,641 130,464
Total Liabilities 9,644,504 9,370,352
Stockholders' Equity    
Preferred stock, par value $0.01 per share; 100,000,000 shares authorized and 29,050,000 shares issued and outstanding ($726,250 liquidation preference) 702,550 702,550
Common stock, par value $0.01 per share; 700,000,000 shares authorized and 344,132,215 and 343,911,324 shares issued and outstanding, respectively 3,441 3,439
Additional paid-in capital 5,629,661 5,625,179
Accumulated other comprehensive (loss) income (145,499) 186,346
Cumulative earnings 1,498,253 1,212,983
Cumulative distributions to stockholders (5,059,102) (4,986,544)
Total Stockholders’ Equity 2,629,304 2,743,953
Total Liabilities and Stockholders’ Equity $ 12,273,808 $ 12,114,305